ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.

HIK Hikma Pharmaceuticals Plc

2,086.00
14.00 (0.68%)
17 Jan 2025 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Hikma Pharmaceuticals Plc LSE:HIK London Ordinary Share GB00B0LCW083 ORD SHS 10P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  14.00 0.68% 2,086.00 2,086.00 2,090.00 2,102.00 2,080.00 2,094.00 345,375 16:35:03
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Pharmaceutical Preparations 2.88B 192M 0.8653 24.13 4.6B
Hikma Pharmaceuticals Plc is listed in the Pharmaceutical Preparations sector of the London Stock Exchange with ticker HIK. The last closing price for Hikma Pharmaceuticals was 2,072p. Over the last year, Hikma Pharmaceuticals shares have traded in a share price range of 1,750.00p to 2,165.00p.

Hikma Pharmaceuticals currently has 221,886,453 shares in issue. The market capitalisation of Hikma Pharmaceuticals is £4.60 billion. Hikma Pharmaceuticals has a price to earnings ratio (PE ratio) of 24.13.

Hikma Pharmaceuticals Share Discussion Threads

Showing 1801 to 1823 of 1875 messages
Chat Pages: 75  74  73  72  71  70  69  68  67  66  65  64  Older
DateSubjectAuthorDiscuss
28/4/2023
08:13
I'm here. This share is overlooked. Sigi's resignation was a bit of a blow and appointing an internal candidate was a vote of no confidence.It's a family firm and it might do OK in the long term.Not for speculators
robertball
28/4/2023
07:37
Reassuring TU with 2 of the 3 segments continuing in-line and the other upgraded. Anyone else here?!?
adamb1978
29/3/2023
20:51
CHC15 - agreed, and planning to add a bit more tomorrow. PE is only just double digits for the current year, yet its trading well, and generates strong ROE, ROCE. Its FCF yield is something like 7%-8% which also signals its probably too cheap
adamb1978
29/3/2023
14:51
Added more this morning, still a long term value play for me.
chc15
03/3/2023
09:00
Needs to break thru resistance at 1779p
misca2
03/3/2023
06:39
Tks W & A for advice.

Agree its topping or is it recovering? That is the question?

Tipped much earlier by our investor group, but I turned down, at the time.

500 @ 1722 (£8610).

Divis, good point, All this type poor, hence why to long AZN rather by buy back in,

Pharmies did come the fore, but can they continue to grow, I say yes, but being from that sphere, I'm biased.

IMO

cheers

dudishes
02/3/2023
19:01
Iain Gilbert
Sharecast News
27 Feb, 2023 16:26 27 Feb, 2023 16:27


Broker tips: Hikma Pharmaceuticals


Analysts at Berenberg raised their target price on drugmaker Hikma Pharmaceuticals from 1,440.0p to 1,740.0p on Monday on the back of the group's recent trading update.

Berenberg stated that last week, Hikma reported "decent" 2022 results, in its view, with no real changes to the group's outlook from January when management presented at a competitor conference.

ariane
02/3/2023
17:46
Upcoming events on HIKMA PHARMACEUTICALS PLC


April/28/2023 Annual General Meeting

waldron
02/3/2023
17:43
RBC raises Hikma Pharma price target to 1,950 (1,750) pence - 'outperform'
waldron
02/3/2023
17:11
LOOKING TOPPY

NOT IMPRESSED WITH DIVI





Having said that if results good, might move up 20pc if EV anything to go by

waldron
23/2/2023
12:52
Thought the results were fine. PE only just into double digits so difficult to see much downside given the expected return to growth this year. Yield of c.3% whilst you wait too. Very comfortable hold for me
adamb1978
23/2/2023
08:20
Actually they are decent, was expecting this, onwards for this, still value, long hold for me.
chc15
23/2/2023
07:42
Pretty awful results, but jam in 2023
18bt
22/2/2023
08:57
This is holding up well, I think tommorow is going to be good.
chc15
10/2/2023
08:27
I'm not sure I'd want companies which I own trying to chase the BoE base rate. Better to have a slower sustainable trend upwards and which is never cut, rather than a sharper increase which then needs cutting in my view
adamb1978
09/2/2023
08:45
Agreed, it's still cheap, I have been buying recently, Feb 23 results.
chc15
08/2/2023
13:45
Share price has had a nice run over the last 3-4 months however is still very cheap if you believe it can grow at mid single digit %s which market forecasts suggest and generate the 20%-ish ROCE which it historically has.

If you believe in mean reversion and see it getting back to multiples over the last few years, this should be heading to £25-£30

adamb1978
08/2/2023
13:32
Perfect from the bottom of the W I've just taken some off the table here.
pk83
25/1/2023
10:50
Adding more today, not a nice drop, no reason for it.
chc15
20/1/2023
10:24
I've started adding here, looks good value, med to long term.
chc15
15/11/2022
13:04
Broker upgrade today with a TP of 17 quid. Not unrealistic at all, IMO, but with the autumn statement on Thursday I have decided to cut and run, slightly before my planned number. GLA.
lovewinshatelosses
07/11/2022
16:03
Took a small position here. Looking for 15 quid, which I think would still not be a frothy valuation. Hopefully they secure a strong appointment for the CEO post and keep on top of costs in this environment. GLA.
lovewinshatelosses
04/11/2022
14:55
It now won't even allow me to spell the company properly !
aclark9201
Chat Pages: 75  74  73  72  71  70  69  68  67  66  65  64  Older

Your Recent History

Delayed Upgrade Clock